Evidence map›Paper›PMID 36791907›Full record

Trial reportContemporary clinical trials2023

Alcohol-focused and transdiagnostic treatments for unhealthy alcohol use among adults with HIV in Zambia: A 3-arm randomized controlled trial.

Michael J Vinikoor, Anjali Sharma, Laura K Murray, Caleb J Figge, Samuel Bosomprah, Chipo Chitambi, Ravi Paul, Tukiya Kanguya, Suilanji Sivile, Van Nghiem and 2 more

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Contemporary clinical trials, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05121064 (Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia), which is not on this map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05121064 nacompletednot on this map

Common Elements Treatment Approach HIV Alcohol Reduction Trial in Zambia

TypeinterventionalSponsorUniversity of Alabama at BirminghamRan2023 to 2025Enrolled680ConditionsHIV/AIDS, Alcohol-Related Disorders, Mental IllnessArmsAlcohol Brief Intervention, Common Elements Treatment Approach, Standard of Care
3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Michael J VinikoorCentre for Infectious Disease Research in Zambia, Lusaka, Zambia; School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA; School of Medicine, University Teaching Hospital, University of Zambia, Lusaka, Zambia. Electronic address: michael.vinikoor@cidrz.org.
Anjali SharmaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Laura K MurrayJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Caleb J FiggeJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Samuel BosomprahCentre for Infectious Disease Research in Zambia, Lusaka, Zambia; School of Public Health, University of Ghana, Accra, Ghana.
Chipo ChitambiCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Ravi PaulSchool of Medicine, University Teaching Hospital, University of Zambia, Lusaka, Zambia.
Tukiya KanguyaCentre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Suilanji SivileZambian Ministry of Health, Lusaka, Zambia.
Van NghiemSchool of Public Health, University of Alabama at Birmingham, Birmingham, AL, USA.
Karen CropseySchool of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
Jeremy C KaneColumbia University Mailman School of Public Health, New York, NY, USA.

Funding

Zambia Alabama HIV Alcohol Comorbidities Program (ZAMBAMA)P01AA029540 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, VINIKOOR, MICHAEL JEFFREY · 2021 to 2025
$5.7M
Improving measurement of alcohol consumption among HIV-affected youth in sub-Saharan Africa: evaluation and implementation of biomarkersK01AA026523 · NIAAA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KANE, JEREMY CALVIN · 2020 to 2024
$881k
NIAAA NIH HHS K01 AA026523NIAAA NIH HHS P01 AA029540
6 · The paper itself

Abstract

backgroundClinical and quality of life outcomes in people living with human immunodeficiency virus (PLWH) are undermined by unhealthy alcohol use (UAU), which is highly prevalent in this population and is often complicated by mental health (MH) or other substance use (SU) comorbidity. In sub-Saharan Africa, evidence-based and implementable treatment options for people with HIV and UAU are needed.

methodsWe are conducting a hybrid clinical effectiveness-implementation trial at three public-sector HIV clinics in Lusaka, Zambia. Adults with HIV, who report UAU, and have suboptimal HIV clinical outcomes, will be randomized to one of three arms: an alcohol-focused brief intervention (BI), the BI with additional referral to a transdiagnostic cognitive behavioral therapy (Common Elements Treatment Approach [CETA]), or standard of care. The BI and CETA will be provided by HIV peer counselors, a common cadre of lay health worker in Zambia. Clinical outcomes will include HIV viral suppression, alcohol use, assessed by audio computer-assisted self-interview (ACASI) and direct alcohol biomarkers, Phophatidylethanol and Ethyl glucuronide, and comorbid MH and other SU. A range of implementation outcomes including cost effectiveness will also be analyzed.

conclusionHybrid and 3-arm trial design features facilitate the integrated evaluation of both brief, highly implementable, and more intensive, less implementable, treatment options for UAU among PLWH in sub-Saharan Africa. Use of ACASI and alcohol biomarkers will strengthen understanding of treatment effects.

Indexed as

HIV InfectionsSubstance-Related DisordersAdultAlcohol DrinkingEthanolHIVHumansQuality of LifeZambiaEthanolHIVPhosphatidylethanolSub-Saharan AfricaTransdiagnostic therapyUnhealthy alcohol use

Identifiers

PMID36791907
PMCPMC10065929

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.